Producer
Phibro Animal Health Corporation
Phibro Animal Health Corporation (Teaneck NJ; NASDAQ: PAHC; ~$1B revenue) manufactures POULVAC brand poultry vaccines (acquired from Fort Dodge/Zoetis divestiture) along with medicated feed additives and nutritional products. Phibro serves commercial poultry producers globally with AI vaccines, Newcastle disease biologics, and coccidiostats.
4
Inputs supplied
3
Goods downstream
2
Facilities
0
Stories
What they make
4 inputs Phibro Animal Health Corporation supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
pharmaceutical
Poultry Biosecurity Inputs & HPAI Vaccines →
pharmaceutical
Dairy Cow Veterinary Pharmaceuticals →
pharmaceutical
Marek's Disease Vaccine (MDV) →
pharmaceutical
Swine Vaccines (PRRSV, PCV2, Mycoplasma) →
Where it shows up
Goods downstream
Essential goods that depend on something Phibro Animal Health Corporation makes, pick one to see the full supply chain.
Where they make it
2 facilities
Phibro Animal Health - Sligo, Ireland →
IEEuropes first Phibro biotech manufacturing plant (2018); autogenous swine vaccines; custom formulation
Phibro Animal Health POULVAC Manufacturing (Charles City IA) →
USIowa · lab
Phibro Animal Health POULVAC poultry vaccine manufacturing. Charles City Iowa facility produces conventional inactivated and live attenuated AI and NDV vaccines for global commercial poultry markets.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Poultry Vaccines (POULVAC)
42%Medicated Feed Additives
35%Nutritional Specialties
23%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Phibro is tracked in supply chain radars as a poultry vaccine company, but its medicated feed additives segment — which includes coccidiostats and in-feed antimicrobials — places it at the center of the antibiotic resistance policy debate. Phibro's feed additives are used in the same broiler flocks as its vaccines, creating a commercial model where one company simultaneously sells disease-prevention biologics (vaccines) and disease-suppression chemicals (antimicrobials) to the same customers. As FDA and EU regulators tighten restrictions on medicated feed additives under antimicrobial resistance frameworks, Phibro faces policy-driven cannibalization of its own revenue streams, with vaccine revenue potentially growing as antibiotic alternatives shrink.
Phibro Animal Health Corporation ↗Origin2023
Phibro Animal Health traces to the Bendheim family's animal health chemicals business, itself a descendant of the Philipp Brothers (PhiBro) commodity trading empire that was one of the largest commodity merchants in the world during the 1970s-80s. PhiBro briefly merged with Salomon Brothers in 1981 to form Phibro-Salomon before unraveling in the late 1980s. The Bendheim family retained the animal health chemicals segment when the larger PhiBro entity was sold; they acquired the POULVAC poultry vaccine portfolio from Pfizer Animal Health (via Fort Dodge and Zoetis divestitures) to build out the biologics side.
Phibro Animal Health Corporation ↗